Nachrichten zur GSK PLC Aktie

GSK hepatitis B drug approval supports £2.2bn sales forecast, Jefferies says

Jefferies has reiterated its buy rating on GSK PLC (LSE:GSK, NYSE:GSK), the pharmaceutical company, with a 2,500p price target after…

Jefferies backs GSK with 2,500p target after positive lung cancer drug results

Jefferies rates GSK PLC (LSE:GSK, NYSE:GSK), the FTSE 100 pharmaceutical company, buy with a 2,500p price target, implying 34% upside from…

GSK third quarter likely to be in line as RBC sees vaccine headwinds offset by HIV strength

GSK PLC (LSE:GSK, NYSE:GSK) is expected to deliver a broadly in-line third quarter as weaker vaccine sales are offset by…

Is the Options Market Predicting a Spike in GSK Plc Stock?

Investors need to pay close attention to GSK stock based on the movements in the options market lately.…

GSK retains ‘buy’ rating at Jefferies as B7H3 cancer programme seen as underappreciated

Investment bank Jefferies has kept its ‘buy’ rating and 2,500p target on GSK PLC (LSE:GSK, NYSE:GSK), the FTSE 100 drugmaker, after…

GSK plc (GSK) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum Transcript

…

GSK splashes up to $750m on experimental cancer therapy

GSK PLC (LSE:GSK, NYSE:GSK) has agreed to pay up to $750 million for an experimental cancer therapy from the privately owned…

Pharma Deutschland: Standort Deutschland ist unter Druck

DRESDEN (dpa-AFX) - Nach dem angekündigten Rückzug des Pharmakonzerns GlaxoSmithKline (GSK ) aus Dresden hat der…

GSK-Impfstoffwerk in Dresden soll nach mehr als 100 Jahren schließen

DRESDEN (dpa-AFX) - Nach 115 Jahren steht die Impfstoffproduktion in Dresden vor dem Aus. Der Pharmakonzern…

GSKs mRNA flu vaccine data closely tracks Modernas, Deutsche Bank says

GSK PLCs (LSE:GSK, NYSE:GSK)  experimental mRNA flu vaccine produced data that closely resemble Modernas own candidate, according to Deutsche Bank....…

GSK shares kept at neutral by Citi as unproven phase III pipeline curbs long-term growth

GSK PLC (LSE:GSK, NYSE:GSK) got a grudging nod from Citi on Thursday, as the investment bank lifted its earnings forecasts for…

GSK Aktie: Kampf gegen die Patentklippe

Wien (www.aktiencheck.de) - GSK-Aktienanalyse der Raiffeisen Bank International AG:Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI), nimmt in einer…

ANALYSE-FLASH: JPMorgan belässt GSK auf 'Underweight' - Ziel 1700 Pence

NEW YORK (dpa-AFX) - Die US-Bank JPMorgan hat die Einstufung für GSK nach Zahlen auf…

Pharmakonzern GSK legt weiter zu - Sparprogramm für mehr Geld für Forschung

LONDON (dpa-AFX) - Der britische Pharmakonzern GSK profitiert weiterhin von guten Geschäften mit Medikamenten unter anderem…

GSK Aktie: Starke Q2-Zahlen - Investitionen in Pipeline angekündigt

Wien (www.aktiencheck.de) - GSK-Aktienanalyse von der Raiffeisen Bank International AG:Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI), nimmt die…

GSK hits three-month high as vaccines help earnings top forecasts

GSK PLC (LSE:GSK, NYSE:GSK) shares jumped to a three-month high after the drugmaker beat second-quarter expectations across its main measures and...…

Jefferies resumes GSK coverage at buy, sees 30% upside on oncology firepower

Jefferies has resumed coverage of GSK PLC (LSE:GSK, NYSE:GSK) with a buy rating and a 2,500p price target, implying roughly 30%…

Jefferies resumes GSK coverage at buy, sees 30% upside on oncology firepower

Jefferies has resumed coverage of GSK PLC (LSE:GSK, NYSE:GSK) with a buy rating and a 2,500p price target, implying roughly 30%…

ANALYSE-FLASH: Jefferies belässt GSK auf 'Buy' - Ziel 2500 Pence

NEW YORK (dpa-AFX Broker) - Das Analysehaus Jefferies hat die Einstufung für GSK auf "Buy"…

UBS keeps GSK at neutral with focus on chief executives strategy update

UBS expects investors to pay little attention to GSK PLCs (LSE:GSK, NYSE:GSK) second-quarter results, with focus shifting instead to a strategy…

UBS keeps GSK at neutral with focus on chief executives strategy update

UBS expects investors to pay little attention to GSK PLCs (LSE:GSK, NYSE:GSK) second-quarter results, with focus shifting instead to a strategy…

GSKs Nuvalent deal tackles HIV cliff to win cautious backing from analysts

GSK PLCs (LSE:GSK, NYSE:GSK) $10.6 billion (£8bn) acquisition of US biotech Nuvalent has achieved something unusual in large pharmaceutical M&A: analysts...…

GSKs Nuvalent deal tackles HIV cliff to win cautious backing from analysts

GSK PLCs (LSE:GSK, NYSE:GSK) $10.6 billion (£8bn) acquisition of US biotech Nuvalent has achieved something unusual in large pharmaceutical M&A: analysts...…

ANALYSE-FLASH: Barclays belässt GSK auf 'Underweight' - Ziel 1800 Pence

LONDON (dpa-AFX Broker) - Die britische Investmentbank Barclays hat die Einstufung für GSK mit einem…

GSK agrees £8bn Nuvalent takeover to bolster oncology pipeline

GSK PLC (LSE:GSK, NYSE:GSK) has agreed to acquire US biotechnology company Nuvalent for $10.6 billion (£8.0 billion), adding "immediate" new sales…

GSK falls after agreeing £8bn Nuvalent takeover to bolster oncology pipeline

GSK PLC (LSE:GSK, NYSE:GSK) shares fell 3% after it agreed to acquire US biotechnology company Nuvalent (NASDAQ:NUVL) for $10.6 billion (£8.0 billion),...…

GSK falls as £8bn takeover of Nuvalent is largest deal in a decade

GSK PLC (LSE:GSK, NYSE:GSK) shares fell 3% after it agreed to acquire US biotechnology company Nuvalent (NASDAQ:NUVL) for $10.6 billion (£8.0…

US bank sees GSK oncology pipeline as major value driver after New York conference

Jefferies has flagged four near-term catalysts in GSK PLCs (LSE:GSK, NYSE:GSK) oncology pipeline following a fireside chat with the pharmaceutical...…

GSK hepatitis B drug a long-term opportunity but US bank holds back from upgrading

Citi is holding back from recommending GSK PLC (LSE:GSK, NYSE:GSK) shares despite a significant clinical breakthrough in hepatitis B treatment, arguing…

GSK Aktie: Starke Zahlen, schwache Pipeline

Wien (www.aktiencheck.de) - GSK-Aktienanalyse von der Raiffeisen Bank International AG:Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI), nimmt die…

ANALYSE-FLASH: DZ Bank senkt Ziel für GSK auf 2100 Pence - 'Halten'

FRANKFURT (dpa-AFX) - Die DZ Bank hat das Kursziel für GSK nach Quartalszahlen von 2200…

GSK Quartalszahlen Q1: Umsatz und Gewinn über Erwartungen

Wien (www.aktiencheck.de) - GSK-Aktienanalyse von der Raiffeisen Bank International AG:Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI), nimmt die…

Pharmakonzern GSK startet überraschend stark ins Jahr - Aktie aber unter Druck

LONDON (dpa-AFX) - Der britische Pharmakonzern GSK hat im ersten Quartal von einer starken Nachfrage…

GSK reaffirms 2026 guidance after strong first-quarter performance

GSK PLC (LSE:GSK, NYSE:GSK), the FTSE 100 pharmaceuticals giant, has reiterated its full-year 2026 guidance after delivering a strong first…

GSK unit wins partial dismissal in dostarlimab licence dispute with AnaptysBio

GSK PLCs (LSE:GSK, NYSE:GSK) oncology subsidiary TESARO has secured a partial legal victory after a Delaware court dismissed a counterclaim brought…

GSK plc (GSK) Presents at Goldman Sachs 9th Annual Biopharma Innovation Summit Transcript

…

Broker reiterates GSK buy as court ruling lifts vaccine cloud

Shore Capital has reiterated its buy recommendation on GSK PLC (LSE:GSK, NYSE:GSK) with a fair value of 2,500p, arguing the pharmaceutical…

Broker reiterates GSK buy as court ruling lifts vaccine cloud

Shore Capital has reiterated its buy recommendation on GSK PLC (LSE:GSK, NYSE:GSK) with a fair value of 2,500p, arguing the pharmaceutical…

GSK sells rights to rare liver disease drug for up to $690m

The British pharma giant will hand off its experimental itch treatment to Italian company Alfasigma as it focuses on broader…

GSK pays $950m for a pulmonary hypertension drug designed to avoid the bleeding risk that limits rival treatments

GSK PLC (LSE:GSK, NYSE:GSK) has agreed to acquire Canadian biotech 35Pharma for $950 million in cash, securing a clinical-stage drug for…

Citi lifts GSK target price but keeps neutral stance after rally

Citi has raised its price target for GSK PLC (LSE:GSK, NYSE:GSK) to £22.50 while maintaining a neutral rating, citing a sharp rally…

ROUNDUP: Pharmakonzern GSK schlägt sich besser als erwartet - Ziele bestätigt

LONDON (dpa-AFX) - Der Pharmakonzern GSK hat dank eines unerwartet starken Schlussspurts im abgelaufenen Jahr…

Pharmakonzern GSK schlägt sich besser als erwartet - Ziele bestätigt

LONDON (dpa-AFX) - Der Pharmakonzern GSK hat dank eines unerwartet starken Schlussspurts im abgelaufenen Jahr…

GSK Aktie: Langsameres Wachstum in 2026

Wien (www.aktiencheck.de) - GSK-Aktienanalyse von der Raiffeisen Bank International AG:Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI), nimmt die…

GSK delivers solid 2025 results, reaffirms growth outlook for 2026

Specialty Medicines drive strong sales as company maintains guidance and raises dividend GSK PLC (LSE:GSK, NYSE:GSK) reported a 7% rise in sales…

GSK snaps up food allergy drug specialist RAPT for $2.2bn

GSK PLC (LSE:GSK, NYSE:GSK) has struck a $2.2 billion deal to buy US biotech firm RAPT Therapeutics, adding a potential new…

GSK reports breakthrough trial results for hepatitis B drug

GSK PLC (LSE:GSK, NYSE:GSK) said on Wednesday that a potential new treatment for chronic hepatitis B had delivered positive late-stage…

GSKs asthma treatment gets greenlight in Japan

GSK PLC (LSE:GSK, NYSE:GSK) said Japan has approved Exdensur (depemokimab) to treat severe or refractory bronchial asthma and chronic rhinosinusitis…

GSK is next to agree drug pricing deal with US government

GSK PLC (LSE:GSK, NYSE:GSK) has become the latest big pharma company to fall into line with the US governments "most favoured…

FTSE 100 Live: London stocks to take a dip, GSK agrees UK pricing deal, Rank hit by fraud

8am: GSK agrees drug pricing deal to avoid tariffs  GSK PLC (LSE:GSK, NYSE:GSK) has become the latest big pharma company to…